CT HB05482

Individual and group health insurance policies must reimburse for a 12-month supply of prescription hormone therapy and administration supplies dispensed at one time, effective January 1, 2027

Prescription hormone therapy covers FDA-approved drugs that suppress, increase, or replace hormones, but explicitly excludes GLP-1 and GLP-1 receptor agonists (weight loss medications)

Medicaid must provide coverage for a 12-month supply of medically necessary prescription hormone therapy and any FDA-approved contraceptive drug, device, or product dispensed at one time

Exceptions allow smaller supplies if the patient requests it, the prescribing provider instructs a smaller supply, or the medication is a controlled substance (in which case maximum refills allowed by law apply)

Health plans may limit refills in the last quarter of the plan year if a 12-month supply has already been dispensed and may apply drug utilization management strategies